Venor®GeM Advance Reference: 11-7096 Ready-to-use mycoplasma detection kit for conventional PCR including loading buffer, marker and polymerase.
DIVERSA Anionic Peptide Delivery Nanoparticles Reference: DIV042 Our Nanoparticle Reagent for Peptide Delivery, based on biocompatible lipids that ensure an efficient interaction with anionic peptides, is essential for advanced peptide therapeutics and for the development of targeted therapies and advanced therapies. It's optimized for peptides with a negative net charge, playing a crucial role in research areas like proteomics, peptide drug development, and targeted therapy. This reagent supports efficient cellular delivery, maintaining peptide integrity and activity, ideal for innovative peptide-based treatments. These lipid nanoparticle formulations can be adapted to various administration routes, facilitating seamless translation from in vitro to in vivo settings, achieved through the development of customized solutions. Nanoparticle reagents for cationic peptides and hydrohobic peptides can be requested as a customized solution.
Wash Buffer (Concentrate 25x) Reference: Ex-P31 Wash Buffer (Concentrate 25x) for TRIFic exosomes assays.
Fetal Bovine Serum, Collected in South America, Exosome Depleted Reference: FBS-ED-12F Fetal Bovine Serum (FBS) is the most frequently used growth supplement for cell culture media. Exosome depleted FBS is suitable for exosome secretion research.
Venor®GeM Advance Reference: 11-7240 Ready-to-use mycoplasma detection kit for conventional PCR including loading buffer, marker and polymerase.
DIVERSA FluoGreen Anionic Peptide Delivery Nanoparticles Reference: DIV042F1 The Fluorescent Nanoparticle Reagent for Peptide Delivery (anionic and negatively charged) utilizing lipid nanoemulsions, emerges as a key asset in biomolecular engineering and peptide therapeutics. With its high fluorescence and non-toxic cellular uptake, it facilitates real-time tracking of peptide-loaded nanoparticles in live cells, providing critical insights into cellular dynamics, drug delivery, and therapeutic peptides. Researchers in fields like oncology, immunotherapy, and personalized medicine rely on this reagent for precision and efficiency. If other fluorescent labels were of preference, please ask DIVERSA for a customized solution. Fluorescent reagents for cationic peptides and hydrohobic peptides can be requested as a customized solution.
Exosome Research - Starting Package Reference: EX11 The pack has been designed to introduce you to our complete range of solutions from isolation to the detection of exosomes in a wide range of applications. This pack is intended both for researchers who are new to the field and existing researchers who would like to try our kit to compare to methods they currently use.
Fetal Bovine Serum, Collected in South America, Low Endotoxin Reference: FBS-LE-12A Fetal Bovine Serum (FBS) is the most frequently used growth supplement for cell culture media. Low endotoxin FBS is suitable for sensitive cells, primary cell culture, and hybridoma cloning.
Venor® GeM qEP Reference: 11-9025 qPCR detection kit including polymerase - EP 2.6.7/ JP, 17st edition, chapter G3 compliant
DIVERSA Protein Delivery Nanoparticles Reference: DIV031 Our Nanoparticle Reagent for Protein Targeted Delivery, leveraging lipid nanoemulsions, is a cornerstone in protein cell internalization. Designed for precision biomedicine and therapeutic evaluation, it facilitates protein delivery with minimal cytotoxicity, ensuring the preservation of protein structure and function. Researchers in protein engineering, targeted therapies, and regenerative medicine benefit from this reagent's efficiency in cellular and molecular biology. DIVERSA’S lipid nanoparticles can avoid tedious cell transfection experiments, ensuring constant intracellular levels of the associated and delivered proteins upon simply addition of the formulation into the cell culture medium. DIVERSA can offer customized solutions with a bioluminescent luciferase for cell tracking. DIVERSA’s lipid nanoparticles can be adapted to various administration routes, facilitating seamless translation from in vitro to in vivo settings, achieved through the development of customized solutions.